One day early vs two days early: where the risk threshold sits The safety calculation changes as you move further from your scheduled day: One day early (day 6 of 7): Blood level difference: approximately 7% higher than intended trough Side effect risk: minimal increase Efficacy impact: none Clinical recommendation: safe for one-time adjustment Two days early (day 5 of 7): Blood level difference: approximately 15% higher than intended trough Side effect risk: modest increase, especially if you're already experiencing nausea Efficacy impact: none Clinical recommendation: acceptable if unavoidable (travel, medical procedure), but not ideal for routine adjustment Three or more days early (day 4 or earlier): Blood level difference: 25%+ higher than intended trough Side effect risk: significant increase in nausea, vomiting, diarrhea Efficacy impact: none, but tolerability suffers Clinical recommendation: contact your provider before dosing The threshold between "safe" and "risky" sits between days 5 and 4

At day 21, participants taking oxaloacetate experienced statistically significant improvement in fatigue as measured by the DePaul Symptom Questionnaire Short Form (DSQ-SF)
The FDA prescribing information does not list generalized skin sensitivity as a recognized adverse reaction, though injection site reactions are well-documented for the subcutaneous formulations (Ozempic and Wegovy)
LyJ.SaingT.Kaur SinghM.Vera TudelaE.MorrisD.et al
But regular chills are, in a way, a side effect of a side effect